The nature of transmission in prion diseases

被引:0
|
作者
Ridley, RM
Baker, HF
机构
关键词
prion; prion disease; BSE; CJD; scrapie; spongiform encephalopathy;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Replicating biological information is usually stored only within nucleic acid. The existence of 'strains' of agent in prion disease (scrapie, BSE, CTD has been taken to indicate an independent genome within the transmissible agent. Other replicable information exists, however, both in biology and elsewhere, including, for example, the 'meme' (the neural correlate of ideas which replicate in human brains by communication) and the computer virus. From this broader viewpoint, we explore the possibility that 'strain' differences in prion disease reflect biological information stored within the prion protein rather than in nucleic acid. Much of the disease variation in mice (used as evidence for strain differences) can be accounted for by the primary structures of the prion protein of the host (the experimentally infected mouse) and the donor mouse (from which infectious tissue is taken). Information determining residual disease variation (when these factors have been excluded) map reside in different conformational states of host prion protein, Prion protein can adopt different conformational and glycosylation states. The information which these states contain is only partially conserved on transmission between animals, permitting the appearance of both 'strain stability' and 'strain mutation'. Different sources of replicating, biological information including information in the 'agent' (the abnormal form of prion protein) and in the host prion gene (PRNP) are in evolutionary competition, We argue that, in the prion diseases, replicating information is not carried in nucleic acid in either the host or the 'agent' but is carried within the conformational state of the abnormal form of prion protein.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [11] Human prion diseases: surgical lessons learned from iatrogenic prion transmission
    Bonda, David J.
    Manjila, Sunil
    Mehndiratta, Prachi
    Khan, Fahd
    Miller, Benjamin R.
    Onwuzulike, Kaine
    Puoti, Gianfranco
    Cohen, Mark L.
    Schonberger, Lawrence B.
    Cali, Ignazio
    NEUROSURGICAL FOCUS, 2016, 41 (01)
  • [12] Molecular Modeling of Prion Transmission to Humans
    Levavasseur, Etienne
    Privat, Nicolas
    Espinosa Martin, Juan-Carlos
    Simoneau, Steve
    Baron, Thierry
    Flan, Benoit
    Torres, Juan-Maria
    Haik, Stephane
    VIRUSES-BASEL, 2014, 6 (10): : 3766 - 3777
  • [13] Immunotherapy for prion diseases: opportunities and obstacles
    Li, Li
    Napper, Scott
    Cashman, Neil R.
    IMMUNOTHERAPY, 2010, 2 (02) : 269 - 282
  • [14] Visual pathology in animal prion diseases
    Ye, Xuemin
    HISTOLOGY AND HISTOPATHOLOGY, 2009, 24 (12) : 1563 - 1577
  • [15] Prion biology and diseases
    Prusiner, SB
    TRANSMISSIBLE SUBACUTE SPONGIFORM ENCEPHALOPATHIES: PRION DISEASES, 1996, : 209 - 237
  • [16] Human prion diseases
    Kretzschmar, HA
    Feiden, W
    PATHOLOGE, 2002, 23 (04): : 241 - 251
  • [17] The diagnosis of prion diseases
    Knight, R
    PARASITOLOGY, 1998, 117 : S3 - S11
  • [18] Human prion diseases
    Wang, Han
    Rhoads, Daniel D.
    Appleby, Brian S.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (03) : 272 - 276
  • [19] Transmission of prion disease
    Blättler, T
    APMIS, 2002, 110 (01) : 71 - 78
  • [20] Prion diseases in man
    Ironside, JW
    JOURNAL OF PATHOLOGY, 1998, 186 (03) : 227 - 234